midgut


Also found in: Dictionary, Medical, Wikipedia.
Related to midgut: midgut volvulus

midgut

[′mid‚gət]
(embryology)
The middle portion of the digestive tube in vertebrate embryos. Also known as mesenteron.
(invertebrate zoology)
The mesodermal intermediate part of an invertebrate intestine.
References in periodicals archive ?
The most important complication of malrotation is midgut volvulus, which can result in intestinal necrosis.
Aim was to give an overview of the literature on left-sided acute appendicitis (LSAA) associated with situs inversus totalis (SIT) and midgut malrotation (MM).
Midgut volvulus is a serious anomaly that develops as a result of narrow attachment of midgut mesentery due to a rotation anomaly, resulting in clockwise twisting of intestinal segments on the superior mesenteric artery axis; it may end up with ischemia and necrosis (1).
cecal diverticulum appears in the 6th week as a swelling on the antimesenteric border of the caudal limb of the midgut loop.
Diagnostic, surgical and medical aspect of the midgut carcinoids.
Safety and efficacy of lanreotide autogel/depot (LAN) every 14 days for patients with pancreatic or midgut neuroendocrine tumours (NETs) progressing on LAN every 28 days: The prospective, international CLARINET FORTE study.
Intraoperatively, midgut volvulus was found with severe ischemic changes of about 35 cm of the proximal jejunum which was dark blue with blackish patches.
Effect of diet delivered various concentrations of double-stranded RNA in silencing a midgut and a non-midgut gene of Helicoverpa armigera.
Malposition of the intestine malposition malrotation volvulus "midgut volvulus".
The approval is for adult patients with somatostatin receptor-positive GEP-NETs and it includes conditions such as foregut, midgut, and hindgut neuroendocrine tumours.
Novartis announced that Advanced Accelerator Applications, a subsidiary of Novartis Groupe S.A., has received US Food and Drug Administration approval of its new drug application for Lutathera for the treatment of somatostatin receptor positive gastroenteropancreatic neuroendocrine tumors, including foregut, midgut, and hindgut neuroendocrine tumors, in adults.
Furthermore, octreotide long-acting repeatable (LAR) has shown antitumor activity against midgut NETs [4].